AEON Biopharma’s Timothy P. Lynch files initial beneficial ownership statement
AEON•Form 3 filing details
AEON Biopharma’s Timothy P. Lynch filed an initial beneficial ownership statement, with an event date of Aug. 19, 2026.
- Reported direct ownership of 5,350,000 shares of Class A common stock.
- Reported derivative holdings of 1,000,000 pre-funded warrants at a $0.0001 exercise price.
- Also disclosed 6,000,000 warrants exercisable from July 15, 2026 at $0.32 or $0.37 per share.
